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Short-chain fatty acids (SCFA), such as sodium butyrate (SB), sodium propionate (SPr),
and sodium acetate (SAc), are metabolic end-products of the fermentation of dietary
fibers. They are linked with multiple beneficial effects on the general mammalian health,
based on the sophisticated interplay with the host immune response. Equine herpesvirus
1 (EHV1) is a major pathogen, which primarily replicates in the respiratory epithelium,
and disseminates through the body via a cell-associated viremia in leukocytes, even
in the presence of neutralizing antibodies. Infected monocytic CD172a+ cells and
T-lymphocytes transmit EHV1 to the endothelium of the endometrium or central nervous
system (CNS), causing reproductive or neurological disorders. Here, we questioned
whether SCFA have a potential role in shaping the pathogenesis of EHV1 during the
primary replication in the URT, during the cell-associated viremia, or at the level of the
endothelium of the pregnant uterus and/or CNS. First, we demonstrated the expression
of SCFA receptors, FFA2 and FFA3, within the epithelium of the equine respiratory
tract, at the cell surface of immune cells, and equine endothelium. Subsequently,
EHV1 replication was evaluated in the URT, in the presence or absence of SB, SPr,
or SAc. In general, we demonstrated that SCFA do not affect the number of viral
plaques or virus titer upon primary viral replication. Only SB and SPr were able to
reduce the plaque latitudes. Similarly, pretreatment of monocytic CD172a+ cells and
T-lymphocytes with different concentrations of SCFA did not alter the number of infected
cells. When endothelial cells were treated with SB, SPr, or SAc, prior to the co-cultivation
with EHV1-inoculated mononuclear cells, we observed a reduced number of adherent
immune cells to the target endothelium. This was associated with a downregulation of
endothelial adhesion molecules ICAM-1 and VCAM-1 in the presence of SCFA, which
ultimately lead to a significant reduction of the EHV1 endothelial plaques. These results
indicate that physiological concentrations of SCFA may affect the pathogenesis of EHV1,
mainly at the target endothelium, in favor of the fitness of the horse. Our findings may
have significant implications to develop innovative therapies, to prevent the devastating
clinical outcome of EHV1 infections.
Keywords: alphaherpesviruses, varicellovirus, short-chain fatty acids, pathogenesis, respiratory tract,
viremia, endothelium
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INTRODUCTION
In the last decades it became clear that nutrition has
a large impact on the immune system of all mammals.
Chronic overnutrition with high-fat meals or rapidly digestible
carbohydrates leads to accumulation of fat in the adipose
tissue, which subsequently becomes infiltrated with immune
cells, inherent with increased systemic concentrations of
inflammatory mediators, such as tumor necrosis factor alpha
(TNFα) and interleukin-6 (IL-6) (Kolb and Mandrup-Poulsen,
2010; Morrison and Preston, 2016). In contrast, increased
consumption of dietary fibers is associated with the reduction
of systemic inflammation and immune disorders (Esposito and
Giugliano, 2006; Anderson et al., 2009). The metabolites of
dietary fibers, such as short chain fatty acids (SCFA) could explain
these anti-inflammatory effects. SCFA, such as butyrate (C4),
propionate (C3) and acetate (C2), are fermentation metabolites
of carbohydrates produced by the intestinal microbiome (den
Besten et al., 2013). In the mammalian gastro-intestinal tract,
SCFA are present in high concentrations in the lumen of
the large intestine, where they are actively metabolized by
the colonic epithelium to produce energy. Moreover, SCFA
are absorbed by the colonic epithelial cells, pass the liver,
and consequently enter the systemic circulation in low, but
measurable concentrations (0.1–10 mM) (Comalada et al., 2006;
Pluznick, 2014). SCFA have been linked with beneficial effects
in the gastro-intestinal inflammatory disorders and protection
from colon cancer in humans. However, little information is
available on the consequences of dietary fibers on local and/or
systemic inflammation and infections in the mammalian body,
including at the respiratory tract and endothelium. SCFA are
thought to elicit their effects via multiple ways. Firstly, SCFA
bind to endogenous G-protein coupled receptors FFA2 and FFA3.
Both receptors are widely expressed on cells, including immune
cells, adipocytes, endothelial cells, and respiratory epithelium
(Li et al., 2018). Binding of SCFA to FFA2, or FFA3 leads to
engagement of the multifunctional adaptor protein, β-arrestin,
triggering the MAPK signaling, which ultimately culminates in
the activation of transcription factors, important for cell growth,
proliferation, and survival (Smith and Rajagopal, 2016). Butyrate
is one of the best-studied SCFA, known to decrease several
pro-inflammatory cytokines, such as TNFα and IL-12, and to
upregulate production of the anti-inflammatory cytokine IL-10.
Moreover, butyrate is associated with the phosphorylation of
STAT-1 and STAT-2, one of the first steps in the IFN-signaling
pathway (Nusinzon and Horvath, 2003; Dedoni et al., 2016).
Secondly, mainly butyrate, and to a lesser extent propionate
inhibit histone deacetylase activity. Histone deacetylases (HDAC)
are ubiquitously expressed in the nucleus and cytoplasm of
immune cells, endothelial cells, and vascular muscle cells (Gray
and Ekstrom, 2001; Zhou et al., 2011; Didonna and Opal,
2015). Inhibiting nuclear HDAC activity results in the enhanced
acetylation of histone proteins, ultimately leading to an open
structure of the chromatin, and enhanced gene transcription
(Reichert et al., 2012).
Horses are experts in hindgut fermentation and are sensitive
to small dietary changes, making them an ideal model to
analyze the consequences of dietary variation on mammal
health (Argenzio, 1975; Janis, 1976; Burkhardt et al., 1997). The
main colonizers within the colon and caecum of Equidae are
proteolytic bacteria, such as Streptococcus spp., and Bacteroides
spp., lactate-utilizing bacteria, predominantly Megasphaera spp.
and Veillonella spp., cellulolytic and fibrolytic bacteria, such
as Butyrivibrio spp., Clostridium spp., Eubacterium spp., and
Ruminococcus spp. (Daly et al., 2001; Julliand, 2005; Dicks
et al., 2014). It is known that a nutrition-related disbalance
between those micro-organisms can lead to a decreased pH,
which ultimately might result in lactate acidosis, colic, anorexia
and in predisposing animals to bouts of laminitis (Biddle
et al., 2013). Moreover, alterations in the intestinal micro-
environment have also been correlated with changes in the course
of several human respiratory diseases, including asthma (De
Filippo et al., 2010; Bisgaard et al., 2011; Abrahamsson et al.,
2014; Bruzzese et al., 2014). However, whether these dietary
factors also affect responses against respiratory and systemic
viral infections is still unknown. In this study, we addressed
the role of the dietary metabolites butyrate, propionate and
acetate on the pathogenesis of one of the most important equine
alphaherpesvirus, the ancient equine herpesvirus 1 (EHV1)
(Karlin et al., 1994).
Horses usually become infected with EHV1 within the first
year of life, which cannot be prohibited by current vaccines
(Lunn et al., 2009). The virus can spread via respiratory
secretions during (in)direct contact between horses. Upon
infection, EHV1 replicates in the epithelium of the upper
respiratory tract (URT), crosses the basement membrane and
enters the blood circulation in single infected immune cells
(Gryspeerdt et al., 2010; Vandekerckhove et al., 2010). EHV1
has evolved the ability to evade the immune surveillance, e.g.,
by misusing monocytic CD172a+ cells and T-lymphocytes as
transport vehicles to reach the endothelium of the pregnant
uterus, or central nervous system (CNS). Infection of the
target endothelium often results in ischemia and thrombo-
embolic disease, eventually causing neonatal foal death, late-
term abortion or myelo-encepthalopathy (EHM) (Edington
et al., 1986, 1991; van der Meulen et al., 2000; Goehring
et al., 2006; Laval et al., 2015a). So far, little information
is known about the role of nutritional metabolites on the
pathogenesis of EHV1. Only one study of Laval et al. (2015a)
demonstrated that the replication of the abortigenic EHV1
strains in monocytic cells is silenced by HDAC at the
level of the viral gene transcription. Treatment of infected
mononuclear cells with butyrate, which suppress HDAC activity,
resulted in the activation of the viral replication. However,
the consequences of SCFA during primary viral replication,
infection of immune cells, and viral transfer to the target
endothelium remains unclear. We hypothesized that SCFA may
impede EHV1 infection of the URT, by hindering virus entry
and/or viral spread in the respiratory epithelium. Secondly,
we hypothesized that SCFA may change the phenotype of
monocytic CD172a+ cells and T-lymphocytes, the main target
cells of EHV1, affecting their susceptibility to viral infection.
Thirdly, since SCFA are known for their anti-inflammatory
properties, we theorized that SCFA may prevent viral transfer
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from infected mononuclear cells to the engaged endothelial
cells. Understanding the fragile balance between host immunity,
metabolic factors, and the viral pathogenesis may be of key
importance to prevent and/or cure the sometimes devastating
consequences of alphaherpesvirus infections.
MATERIALS AND METHODS
Virus
One Belgian EHV1 strain was included in this study and was
genotyped in the ORF30 region by the Animal Health Trust
in the United Kingdom. The 97P70 EHV1 strain, encoding an
asparagine at amino acid position 752 (N752) (Nugent et al.,
2006), was originally isolated in 1997 from the lungs of an aborted
fetus (van der Meulen et al., 2003; Van de Walle et al., 2009). Virus
stock of 97P70 was used for inoculation at the 6th passage. The
last passage was performed in RK-13 cells.
Respiratory Mucosa Explants and Cells
Respiratory Mucosa Explants
Respiratory tissues from horses were collected post mortem
in the slaughterhouse, approved by the Ethical committee of
Ghent University (2018_NOPROC_01). Horses negative for
ocular/nasal discharge and lung pathologies were selected. The
horses were aged between 5 and 15 years old, as determined
by inspection of dental incisive architecture (Muylle et al.,
1996). Each experiment was conducted with tissues from three
different horses. The proximal part of the trachea was collected
from each horse. Tissues were transported to the laboratory
on ice, in phosphate-buffered saline (PBS), supplemented with
1% gentamycin, 1% penicillin-streptomycin (Gibco, Invitrogen,
Paisley, United Kingdom), 1% kanamycin (Sigma-Aldrich, St.
Louis, MO, United States) and 0.5% amphotericin B (Bristol-
Myers Squibb). Respiratory mucosa explants were collected and
cultivated as described previously by Vandekerckhove et al.
(2010) and Poelaert et al. (2018).
Cells
Isolation of equine blood CD172a+ cells and T-lymphocytes
Peripheral blood was sampled from the external vena jugularis
into heparin (Leo, Zaventem, Belgium) at a final concentration of
15 U ml−1. The Ethical Committee of the Faculty of Veterinary
Medicine, Ghent University (application EC2017/118) approved
the collection of blood. Isolation of PBMC was conducted as
previously described by Poelaert et al. (2019). Briefly, fresh
blood was diluted in an equal volume of Dulbecco’s phosphate-
buffered saline (DPBS) without calcium and magnesium (Gibco).
Peripheral blood mononuclear cells (PBMC) were isolated by
density centrifugation on Ficoll-Paque (d = 1.077 g ml−1) (GE
Healthcare, Life Sciences) at 800 × g for 30 min at 18◦C. The
interphase band, containing the PBMC, was collected and washed
three times with DPBS. Cells were resuspended in complete
medium based on Roswell Park Memorial Institute (RPMI)
(Gibco), supplemented with 5% newborn fetal calf serum (FCS)
(Gibco), 1% non-essential amino acids, 1% sodium pyruvate, 1%
penicillin-streptomycin, 0.5% gentamycin (Gibco). Afterward,
PBMC were seeded at a concentration of 5 × 106 cells per
ml and cultivated at 37◦C with 5% CO2. After 2 h, non-
adhering leukocytes were removed by washing cells three times
with RPMI and the adherent cells were cultured in complete
medium. Non-adherent cells were washed 3 times with ice-
cold RPMI. The cell pellet was incubated with 400 µl of mouse
monoclonal (mAb) anti-horse pan B-cell, clone CVS36 (IgG1;
1:50) (Biorad, United States) diluted in ice-cold DPBS, for 1 h at
4◦C with gentle agitation. Afterward, cells were washed once in
magnetic-activated cell sorting (MACS) buffer containing DPBS
supplemented with 1 mM EDTA and 5% newborn FCS and
incubated with 400 µl rat anti-mouse IgG1 microbeads (MACS
Miltenyi Biotec, Bergisch Gladbach, Germany) diluted in MACS
buffer (1:5), for 1 h at 4◦C with gentle agitation. Next, the cells
were washed once in MACS buffer and resuspended in 3 ml
MACS buffer for application to the MACS column. The unbound
cells of the pan-B-cell antibody-incubated T-lymphocytes were
collected from the column and consisted of >90% of CD3+
cells, assessed by flow cytometry after incubation with a mAb
anti-CD3, clone UC-F6G (IgG1; 1:50) (UC Davis, Davis, CA,
United States), directed against cells from the T-cell lineage,
followed by goat anti-mouse IgG FITC (1:200) (Molecular
Probes) (data not shown). All T-lymphocytes were cultured
in complete medium supplemented with 4 U ml−1 human
recombinant interleukin-2 (hIL-2) (R&D systems) and 50 mM
β-mercaptoethanol (β-ME) (Gibco).
Equine venous endothelial cell culture
Laval et al. (2015b) previously reported the isolation and
immortalization of equine venous endothelial cells (EC). EC
were maintained in EC medium containing Dulbecco’s modified
Eagle Medium (DMEM) (Gibco) supplemented with 5% FCS
and antibiotics. Firstly, to analyze the effects of Sodium Butyrate
(SB), Sodium Propionate (SPr), or Sodium Acetate (SAc) (Sigma-
Aldrich) on the expression of adhesion molecules on the EC
plasma membrane, EC were grown to confluence in 6-well plates
coated with 10 µg ml−1 fibronectin from bovine plasma (Sigma-
Aldrich). Twenty-four hours prior to collection, EC were cultured
in EC medium supplemented with 0 or 5 mM SCFA. Previous
studies demonstrated that lipopolysaccharide (LPS) stimulation
of vascular endothelium increases the expression of ICAM-1 and
VCAM-1 on the cellular plasma membrane (Faure et al., 2000;
Hijiya et al., 2002; Zeuke et al., 2002; Dauphinee and Karsan,
2006). Therefore, in this study EC were pretreated 3 h prior to
collection with 0 or 10 µg ml−1 LPS derived from Escherichia coli
(Sigma-Aldrich), to analyze the effects of SCFA on the expression
of the adhesion molecules.
Secondly, to analyze the co-cultivation of EHV1-inoculated
mononuclear cells and EC in the presence or absence of SCFA,
EC were grown to confluence in 8-well Lab-Tek II chamber
slides (Thermo Fisher Scientific, Rochester, NY, United States)
coated with 10 µg ml−1 fibronectin. Six hours prior to co-
cultivation with PBMCs, medium was substituted by EC medium
supplemented with 0, 0.5, or 5 mM SB, SPr, or SAc.
Finally, EC were cultured as previously described in 8-well
Lab-Tek II chamber slides and treated with 0.5 or 5 mM SB,
SPr, or SAc during 24 h prior to EHV1 inoculation. Different
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concentrations of SCFA were maintained throughout inoculation
and cultivation of EC.
Rabbit kidney epithelial (RK13) cells
Rabbit kidney epithelial cells were purchased from the American
Type Culture Collection (ATCC, Manassas, VA, United States)
and were used in this study to analyze EHV1 replication, by
quantifying extracellular virus titers at different time points post
inoculation. Cells were maintained in MEM supplemented with
antibiotics and 5% FCS.
Cell Viability
Cell viability of the SCFA-pretreated mononuclear cells and EC
was determined by flow cytometry, using 1 µg ml−1 propidium
iodide (Sigma-Aldrich), prior to virus inoculation and was >90%
in all cell populations. An in situ Cell Death Detection Kit
(Fluorescein) based on Terminal deoxynucleotidyl transferase
mediated dUTP Nick End Labeling (TUNEL) was obtained
from Roche (Mannheim, Germany) and used to detect DNA
fragmentation induced by apoptotic signaling cascades. The
co-localization of incorporated dUTP in respiratory mucosa
epithelium and lamina propria was analyzed with fluorescence
microscopy (Leica DM RBE microscope, Leica Microsystems
GmbH, Heidelberg, Germany). The number of TUNEL positive
cells was evaluated in five randomly chosen fields of the
epithelium and the lamina propria. No significant differences
were observed between SCFA-treated mucosa explants and the
control (data not shown).
EHV1 Inoculation
Pretreatment and Inoculation of Respiratory
Mucosa Explants
Serum-free medium (DMEM/RPMI, supplemented with
antibiotics) containing 0, 0.5 or 5 mM SB, SPr or SAc, were
added 24 h prior to inoculation and maintained throughout the
inoculation and cultivation of the explants. After 24 h of culture,
explants were taken from their gauzes and placed in a 24-well
plate with the epithelial surface upward. Warm serum-free
medium was used to wash them twice. Explants were inoculated
with EHV1, as previously described by Vandekerckhove et al.
(2010). Briefly, inoculation took place by the immersion of the
explant in 1 ml inoculum, containing 106.5 TCID50 of EHV1,
for 1 h at 37◦C. After inoculation, explants were washed twice
in warm serum-free medium and transferred to their gauzes.
At 24 hpi mucosa explants were collected and embedded in
methylcellulose medium (Methocel R© MC, Sigma-Aldrich) and
frozen at−70◦C. Supernatant was collected and stored at−70◦C
until further use.
Pretreatment and Inoculation of Monocytic CD172a+
Cells and T-Lymphocytes
CD172a+ monocytic cells and T-lymphocytes were inoculated
with EHV1 at a multiplicity of infection (MOI) of 5, for 1 h at
37◦C. Where mentioned, complete medium supplemented with
0, 0.5 or 5 mM SB, SPr or SAc was added 24 h prior to inoculation
and was maintained throughout the (mock)-inoculation and
cultivation of the mononuclear cells.
Binding and Co-cultivation Assay of EHV1-Inoculated
Mononuclear Cells With Equine Endothelial Cells
To analyze the PBMC binding and EHV1 transfer to equine EC
in the presence of SCFA, we assessed a PBMC binding assay
and co-cultivation assay. Briefly, mock- or EHV1 inoculated
monocytic CD172a+ cells or T-lymphocytes were collected at
12 hpi and washed with citrate buffer containing 40 mM citric
acid, 135 mM NaCl, 10 mM KCl (pH 3), during 1 min at RT,
to neutralize cell-free virus particles. Cells were rinsed three
times, to remove redundant citrate buffer, and T-lymphocytes
were resuspended in 200 µl complete medium supplemented
with 0, 0.5 or 5 mM SB, SPr or SAc. CD172a+ monocytic cells
were detached by incubating with pure AccumaxTM solution
(Sigma-Aldrich) for 30 min at 37◦C, and were collected in
ice-cold falcon tubes containing FCS to neutralize the enzyme
activity. Monocytic cells were resuspended in 200 µl ice-cold
complete medium supplemented with 0, 0.5 or 5 mM SB, SPr or
SAc. Both subsets of mononuclear cells were layered on SCFA-
treated equine EC monolayers, prior to co-cultivation (ratio
of 2:1). Cells were further co-cultured for 15 min, 60 min
(binding assay) or 36 h (co-cultivation assay) at 37◦C, 5%
CO2. EC and adherent mononuclear cells were fixed with
100% methanol (−20◦C, 20 min) and stored in −20◦C until
further processing.
Pretreatment and Inoculation of Equine Venous
Endothelial Cells
Endothelial cells medium (DMEM, supplemented with 5% FCS
and antibiotics) containing 0, 0.5 or 5 mM SB, SPr or SAc, was
added 24 h prior to inoculation and maintained throughout the
inoculation and cultivation of the EC. After 24 h of culture, EC
were washed twice in DMEM containing different concentrations
of SCFA. EC were inoculated at a MOI of 5, for 1 h at 37◦C. At 24
hpi, EC were fixed and supernatants was collected.
Virus Titrations
The extracellular viral titer was determined in supernatant
from respiratory mucosa explants, monocytic CD172a+ cells,
T-lymphocytes, and EC inoculated with cell-free virus. Virus
titers were assessed by a 50% tissue culture infective dose assay
using RK13 cells. The 50% end-point was calculated according to
the method of Reed and Muench (1938).
Bioassay for Determining Interferon
Antiviral Activity
Supernatants of EHV1- and mock-inoculated SCFA-pretreated
tracheal explants were harvested at 24 hpi. Type I interferon
(IFN) bioactivity was determined by a cytopathic effect (CPE)
reduction assay based on vesicular stomatitis virus (VSV)
and Madin-Darby bovine kidney (MDBK) cells as previously
described in La Bonnardiere and Laude (1981) and Poelaert
et al. (2018). Briefly, MDBK cells were seeded in 96-well micro
titer plates in DMEM with 5% FCS, 1% sodium pyruvate,
1% penicillin-streptomycin solution and 1% gentamycin. After
overnight incubation at 37◦C, 5% CO2, medium was removed
and serial two-fold dilutions of samples were added to the
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confluent cells. Following 18 h incubation (37◦C, 5% CO2), 50 µl
of VSV was added to the samples and virus control wells, at a
concentration resulting in complete CPE after 48 h. To the cell
control wells, only 50 µl of medium was added. Following 48 h
incubation, medium was aspirated and 50 µl of 0.1% neutral
red solution was added to the cells during 1 h at 37◦C in 5%
CO2. Next, cells were rinsed, air-dried and 150 µl of dissolving
solution (50 µl sodium lauryl sulfate (SDS), 100 µl 0.2 M HCl
in H2O) was added. The absorbance of neutral red solution at
492 nm was determined with a micro-plate reader. The IFN
titer was calculated as the reciprocal of the last IFN dilution
causing 50% inhibition of virus-induced CPE and was expressed
as IFN units per volume. Recombinant EqIFNα (Kingfisher
Biotech Inc., Saint Paul, MN, United States) with a titer of
18 × 103 U ml−1 was run in each assay as positive control.
The relative IFN (rIFN) bioactivity upon SCFA treatment was
calculated by standardizing the values with the correspondent
extracellular virus titer.
Indirect Immunofluorescence Staining
SCFA Receptors
Fifty consecutive cryosections of 16 µm were made of
the respiratory and lymph nodal tissues derived from three
individual horses. The frozen sections were mounted on 3-
aminopropyltriethoxysilane (Sigma-Aldrich) coated slides, and
fixed in 4% paraformaldehyde (PFA) for 10 min at room
temperature (RT). The sections were washed two times in
DPBS, and permeabilized in 0.1% Triton X-100, during
10 min at RT. Subsequently, the sections were rinsed twice in
DPBS, and incubated with a rabbit polyclonal antibody (pAb)
against GPR43 (IgG, 1:50 in DPBS) or rabbit pAb against
GPR41 (IgG, 1:50 in DPBS) (Thermo Fisher Scientific) to
visualize FFA2 or FFA3, respectively. Subsequently, the sections
were incubated with a FITC-conjugated goat anti-rabbit IgG
antibody (1:100 in DPBS) (Molecular Probes, Eugene, OR,
United States). All antibodies were incubated for 1 h at 37◦C.
Cell nuclei were counterstained with Hoechst 33342 (10µg ml−1)
(Molecular probes).
Viral Proteins
Respiratory mucosa explants
At 24 hpi, fifty consecutive cryosections of 16 µm were
made of the frozen explants derived from three horses. The
frozen sections were mounted on 3-aminopropyltriethoxysilane
coated slides. They were fixed in 100% methanol for 20 min
at −20◦C, and then washed with DPBS. Late viral proteins
were stained with biotinylated equine polyclonal anti-EHV1
IgG antibody (1:20 in DPBS) (van der Meulen et al., 2003),
followed by streptavidin FITC (1:200 in DPBS) (Molecular
Probes). Subsequently, the basement membrane of the explants
was stained by incubation with a mouse monoclonal anti-
collagen VII IgG1 antibody (clone LH7.2; 1:50 in DPBS) (Sigma-
Aldrich), followed by a Texas Red R©-conjugated goat anti-mouse
IgG antibody (1:200 in DPBS) (Molecular Probes). Antibodies
were incubated for 1 h at 37◦C. Cell nuclei were counterstained
with Hoechst 33342 (10 µg ml−1). Determinations of viral
plaque numbers and plaque latitude were data obtained from 50
consecutive cryosections.
Mononuclear cells
Monocytic CD172a+ cells and T-lymphocytes were collected at
12 hpi. Monocytic CD172a+ cells were fixed in 100% methanol
for 20 min at −20◦C, whereas T-lymphocytes were fixed in 1%
PFA during 10 min at RT and washed two times with DPBS.
T-lymphocytes were prepared for immunofluorescence staining
using cytospin-centrifugation (7 min, 700 rpm). Next, T-cells
were permeabilized with 0.1% Triton X-100 during 2 min at RT.
All mononuclear cells were incubated for 1 h at 37◦C with a rabbit
pAb against IEP (1:1000) (Smith et al., 1994; Jang et al., 2001)
to visualize immediate early protein (IEP). The IEP antibody
was kindly provided by Prof. Dr. O’Callaghan (United States).
Subsequently, cells were incubated during 50 min at 37◦C with
goat anti-rabbit IgG FITC (1:100). All antibodies were diluted
in DPBS. Cell nuclei were counterstained with Hoechst 33342
(10 µg ml−1) (Molecular probes).
Equine venous endothelial cells
Firstly, to visualize the transfer of infection from
EHV1-inoculated mononuclear cells to EC a double
immunofluorescence staining was carried out after 36 h
of co-cultivation. Late viral proteins were stained with the
biotinylated pAb against EHV1 (1:20). Next, cells were incubated
during 50 min at 37◦C with streptavidin FITC (1:200) and nuclei
were counterstained with Hoechst 33342 (10 µg ml−1). Secondly,
to visualize the viral replication in EC in presence of different
concentrations of SCFA, cells were incubated during 1 h at 37◦C
with the biotinylated pAb against EHV1 (1:20), to visualize late
viral proteins. Next, EC were incubated with streptavidin FITC
(1:200) during 50 min, 37◦C. Cell nuclei were counterstained
with Hoechst 33342 (10 µg ml−1).
Adhesion molecules
To analyze the effects of SCFA on equine EC, an indirect
immunofluorescence staining for ICAM-1 and VCAM-1 was
carried out. Briefly, EC pretreated with 0 or 5 mM SB, SPr, or
SAc were detached with pure AccumaxTM solution for 10 min,
37◦C, and were collected in ice-cold falcon tubes containing FCS
to neutralize the enzyme activity. Cells were immediately fixed
in 1% PFA for 10 min at RT, rinsed twice with DPBS, followed
by cytospin centrifugation. EC were washed and incubated with
a mouse monoclonal antibody (mAb) against ICAM-1 (IgG1,
1:50 in DPBS) (Invitrogen), mouse mAb against VCAM-1 (IgG2a,
1:50 in DPBS) (Biorbyt Ltd., Cambridge, United Kingdom) or
irrelevant isotype controls during 60 min at 4◦C. Next, cells were
incubated during 60 min at 4◦C with goat anti-mouse IgG TR
(1:100 in DPBS). Cell nuclei were counterstained with Hoechst
33342 (10 µg ml−1).
Confocal Microscopy
Immunofluorescence staining of all cells was analyzed by
confocal microscopy (Leica TCS SP2 Laser Scanning Spectral
Confocal System; Leica Microsystems). A Gre-Ne 543 nm laser
was used to excite Texas Red-fluorochromes. An Argon 488 nm
laser excited FITC-fluorochromes.
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Statistical Analysis
Analyzed data for statistical significance were subjected to a
multiple-way analysis of variance (ANOVA). The Dunnett-test
was used as a post hoc test. If the assumption of equal variables
was not fulfilled with the Levene’s test, the data were log-
transformed prior to ANOVA. Normality of the residuals was
verified by the use of the Shapiro–Wilk test. A Kruskall–Wallis’
test, followed by a Mann–Whitney’s post hoc test was performed
when variables remained unequal or when normality was not
achieved after log-transformation. Differences in results with
p-values < 0.05 were considered statistically significant. The
data shown represent means + SD of independent experiments.
Extreme values, also called outliers were detected with the
“Median Absolute Deviation (MAD)” method, described by Leys
et al. (2013). Outliers were excluded from the statistical analysis.
Data were statistically evaluated with IBM SPSS Statistics for
Windows, version 24.0 (IBM Corp., Armonk, NY, United States).
RESULTS
SCFA Receptors Are Expressed on the
Cell Surface of Multiple Cell Types of the
Horse
Cryosections of respiratory (nasal septum, trachea, and lung)
and lymph nodal tissue samples were made, followed by indirect
immunofluorescence staining for the two main SCFA receptors,
FFA2 and FFA3. In nasal and tracheal mucosa, both FFA2
and FFA3 receptors were diffusely expressed in the epithelium
lining the luminal surface (Figure 1). FFA2 was more extensively
expressed by the epithelial cells compared to FFA3. In addition, a
similar expression pattern of FFA2 and FFA3 was detected in the
epithelium lining the bronchial and lung lumen. Both receptors
were expressed by immune cells present in the lymph nodes
and by the endothelium lining the blood vessels. Taken together,
SCFA receptors FFA2 and FFA3 are present at the luminal surface
of the equine respiratory tract and blood vessels, and on the cell
surface of circulating immune cells.
SPr and SB, but Not SAc Hinders Primary
EHV1 Replication in the Upper
Respiratory Tract
Previous studies demonstrated that SCFA, produced by
microbiota in the gastro-intestinal tract, may be absorbed
through the colonic epithelium, disseminate in peripheral blood,
and may reach the respiratory tract (Cummings et al., 1987;
Trompette et al., 2014). Since SCFA receptors are expressed
by epithelial cells in the URT, we determined whether sodium
butyrate (SB), sodium propionate (SPr), and/or sodium acetate
(SAc) increase primary viral replication in the URT. No
significant difference in extracellular virus titer was measured
between mock- or SCFA-treated mucosal explants, independent
of the concentration used (Figure 2A). Viral plaques became
significantly smaller compared to control (101 ± 38 µm) when
the explants were pretreated with 0.5 mM SB (43 ± 4 µm)
(p < 0.05) and 0.5 mM SPr (66 ± 46 µm) (p < 0.05). No
significant reduction in viral plaque latitudes was detected when
increasing the concentration of SB (p > 0.05) or SPr (p = 0.1)
to 5 mM. Only 5 mM of SAc significantly reduced the plaque
latitudes to 45 ± 19 µm (p < 0.05) (Figure 2B). Representative
confocal images are shown in Figure 2C. The number of viral
plaques in the respiratory mucosa explants pretreated with SCFA
did not significantly alter compared to control (Figure 2D).
Noteworthy, viral plaques in SB-treated mucosa explants were
observed in the apical part of the respiratory epithelium,
suggesting a more efficient plaque sequestration and viral
clearance in the URT in the presence of sufficient concentrations
of butyrate. Taken together, we can conclude that 0.5 mM of SB
and SPr reduces the lateral spread of EHV1 in the URT, resulting
in smaller viral plaques. Higher concentrations of SPr and SAc
(marginally) reduced the size of the viral plaques.
SCFA Does Not Activate the Innate
Response in the Upper Respiratory Tract
After EHV1 Infection
The innate recognition of alphaherpesviruses is principally
orchestrated by type I interferon (IFN). In a previous study
we demonstrated that type I IFN is induced upon EHV1
replication in the URT (Poelaert et al., 2018). Nusinzon and
Horvath (2003) indicated a putative stimulatory role of butyrate
on the phosphorylation of STAT-1 and -2, one of the first
steps in the IFN-signaling pathway. Based on those reports,
we hypothesized that SCFA might regulate the innate immune
response in the URT of the horse, by activating the IFN signaling
pathway. Therefore, the production of bioactive type I IFN
was measured in the supernatants of EHV1-inoculated tracheal
mucosa explants treated with 0 or 5 mM of SB, SPr or SAc.
Results are shown in Figure 2E as percentage of control. No
significant differences in type I IFN levels were detected between
SB, SPr, or SAc treated explants (p > 0.05). Taken together, SCFA
pretreatment did not activate the production of type I IFN in
EHV1-infected respiratory mucosa explants of the horse.
SCFA Does Not Change Infection of
Blood Mononuclear Cells
Short-chain fatty acids have been demonstrated to modulate the
phenotype, metabolism and function of cells of the immune
system. Indeed, butyrate, propionate and acetate mediate
T-lymphocyte proliferation in vitro (Franklin et al., 1991; Wajner
et al., 1999). However, little information is available of the role of
SCFA on EHV1 infections of mononuclear cells. Since EHV1 has
a prominent ability to infect immune cells and more efficiently
infects (IL-2) activated T-lymphocytes (van der Meulen et al.,
2000; Poelaert et al., 2019), we hypothesized that SCFA might
reduce EHV1 infection of mononuclear cells by interfering with
immune cell proliferation or by changing cellular phenotypes,
and thus impeding the cell-associated viremia.
Here, viral infection of the mononuclear cells in the
presence or absence of SCFA was analyzed by indirect
immunofluorescence staining. The number of EHV1-
infected monocytic and T-cells are shown as percentage of
control in Figures 3A,B. Pretreatment of monocytic cells and
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FIGURE 1 | Immunofluorescence staining of the two main SCFA receptors, FFA2 (left panel) and FFA3 (right panel) in respiratory and lymph nodal tissues isolated
from healthy horses. After collection, tissues were snap-frozen in liquid nitrogen. Both receptors were stained in green (FITC), nuclei were counterstained in
blue (Hoechst).
T-lymphocytes cells with 0.5 or 5 mM SB did not significantly
alter the number of EHV1 infected cells, compared to control
(p > 0.05). Similarly, for the cells treated and incubated with
SPr showed no significant differences with regard to number of
EHV1 positive cells, compared to control (p > 0.05). A 1.5-fold
reduction in EHV1-positive monocytic CD172a+ cells, but not
EHV1-positive T-cells, was observed upon pretreatment and
cultivation with 0.5 mM SAc (p < 0.05). However, increasing the
concentration of SAc did not significantly alter the number of
EHV1 infected monocytic cells (p > 0.05).
Supernatants of EHV1-inoculated immune cells were
analyzed by virus titration to quantify the extracellular virus
titers. A marginally higher virus titer was observed when
the monocytic cells were pretreated with 0.5 and 5 mM SB,
compared to control (p = 0.179 and p = 0.165, respectively)
(Figures 3C,D). In contrast, no changes in virus titer were
detected when monocytic CD172a+ cells were treated with SPr
(p = 0.909 and p = 0.999, respectively), or SAc (p = 0.237 and
p = 0.497, respectively). Treatment of the T-lymphocytes with
SFCA did not affect the extracellular virus titer. Taken together,
these results indicate that SCFA do not directly affect the ability
of EHV1 to infect monocytic CD172a+ cells or T-lymphocytes.
Only SAc reduced the number of EHV1 infected monocytic
cells at the concentration of 0.5 mM. EHV1 replication in
CD172a+ mononuclear cells was slightly more productive in
the presence of SB.
SCFA Reduces the Adhesion of
Blood-Derived Monocytic Cells and
T-Lymphocytes to Equine
Endothelial Cells
Since the adhesion of EHV1-infected mononuclear cells is
a crucial step in viral transfer to the target endothelium,
we analyzed the effects of SCFA on the equine endothelial
cells (EC). Mock- or EHV1-inoculated monocytic cells and
T-lymphocytes were used as model to analyze the binding
capacities of PBMC to SCFA-treated target EC. After 15 min
of co-cultivation with 0.5 mM SCFA, no significant differences
in binding capacity of mock- or EHV1-inoculated monocytic
cells or T-lymphocytes were observed between control and the
different SCFA pretreatments. Upon pretreatment with 5 mM
SB and SPr, the percentage of bound mock-inoculated T-cells
decreased to 36 ± 19% (p < 0.05) and 41 ± 18% (p < 0.05),
Frontiers in Microbiology | www.frontiersin.org 7 April 2019 | Volume 10 | Article 723
fmicb-10-00723 April 4, 2019 Time: 18:3 # 8
Poelaert et al. SCFA Moderate Herpesvirus Pathogenesis
FIGURE 2 | Evaluation of EHV1 replication in the presence of SB, SPr, or SAc in the upper respiratory tract. (A) Extracellular virus titer, and (B) viral plaque latitudes
were analyzed at 24 hpi. (C) Representative confocal images of EHV1 plaques in tracheal mucosa explants are stained in green (FITC). Basement membrane is
shown in red (TR), and nuclei were counterstained in blue (Hoechst). The effects of SCFA on (D) the number of viral plaques in tracheal mucosa explants.
(E) Evaluation of type I interferon (IFN) bioactivity in EHV1-inoculated tracheal mucosa explants in the presence of SB, SPr, or SAc. Ten ad random chosen viral
plaques were analyzed. Three independent experiments were performed and data are represented as means + SD. Statistical significant differences are shown with
asterisks: ∗ p < 0.05; ns indicates p > 0.05.
respectively, compared to 100% bound T-cells in control-treated
EC (Figures 4A–D, left panels). This trend of reduction increased
upon 60 min of co-culture. Indeed, pretreatment with 0.5 mM
significantly reduced the number of bound mock-inoculated
monocytic and T-cells to the EC surface (Figures 4A,C, right
panel). Increasing the concentration of all SCFA did not further
reduce the number of adherent mononuclear cells to the EC
surface, compared to control. Upon 60 min co-cultivation of
EHV1-inoculated monocytes and 0.5 mM SB or SPr pretreated
EC, the percentage of bound monocytic cells decreased to
28± 31% (p = 0.086) or 22± 18% (p = 0.063), compared to 100%
bound monocytes in the control conditions. Pretreatment of EC
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FIGURE 3 | Analysis of SCFA pretreatment on EHV1 infection of mononuclear cells. The number of immediate early protein (IEP) positive (A) monocytic CD172a+
cells and (B) T-lymphocytes at 12 hpi. The extracellular virus titer were analyzed in the supernatants of the EHV1-inoculated (C) monocytic CD172a+ cells and
(D) T-lymphocytes. Five ad random chosen fields of 100 cells were analyzed. Three independent experiments were performed and data are represented as
means + SD. Statistical significant differences are shown with asterisks: ∗ p < 0.05; ns indicates p > 0.05.
with 0.5 mM SAc did not alter the percentage of bound monocytic
cells to the EC (48 ± 60%) (p = 0.242). Similar results were
observed for T-lymphocytes upon pretreatment with 0.5 mM SB,
SPr, or SAc. Treatment with 5 mM SB or SPr resulted in a 30-
fold (p < 0.01) reduction of bound monocytic cells, compared
to control. Similarly, a 5-fold (p < 0.05) or 3-fold (p < 0.05)
reduction of bound T-lymphocytes was detected upon treatment
with 5 mM SB, or SPr, respectively. Comparably, pretreatment
with 5 mM SAc reduced the number of adherent monocytes
(p < 0.01) and T-lymphocytes (p < 0.05) (Figures 4B,C, right
panels). Figure 4E shows representative confocal images of the
binding of EHV1-inoculated mononuclear cells to the target
endothelium, pretreated with SCFA. These results show that
SCFA treatment reduces the number of adherent immune cells
to the endothelium.
To better understand this reduced adhesion, we analyzed
whether the expression of ICAM-1 and VCAM-1 adhesion
molecules on the endothelial cell surface was downregulated after
SCFA treatment. To this end, we incubated endothelial cells with
SB, SPr, or SAc, followed by the pretreatment with or without
LPS, during 3 h. Since LPS stimulates the upregulation of ICAM-
1 and VCAM-2 (Faure et al., 2000; Hijiya et al., 2002; Zeuke
et al., 2002; Dauphinee and Karsan, 2006), we analyzed whether
SCFA interfered with the LPS-mediated upregulation of those
adhesion molecules. In the absence of LPS, only 13 ± 3% of the
EC expressed ICAM-1 on their plasma membrane (Figure 5A).
Pretreatment with SB, or SPr, did not substantially affect this
percentage (11 ± 4%, 13 ± 4%, respectively). Pretreatment with
SAc decreased the ICAM-1 expression on the endothelial surface
(8± 3%) (p < 0.05). Treatment with LPS resulted in a significant
upregulation of ICAM-1 on the cell surface (p < 0.001). SB
(p < 0.05), SPr (p < 0.01) and SAc (p < 0.001) pretreatment
significantly reduced the ICAM-1 expression on the EC surface,
compared to control.
VCAM-1 expression on EC without LPS-treatment, showed
marginal differences between SAc (17 ± 10%) and control
(24± 7%) treated EC (p = 0.062) (Figure 5B). Treatment with SB
(10± 4%) or SPr (8± 5%) did downregulate VCAM-1 expression
on the plasma membrane, p < 0.001, and p < 0.001, respectively.
When EC were treated with LPS, a significant upregulation of
VCAM-1 was observed (p < 0.001), though a similar reduction
in the VCAM-1 expression was observed when treated with SB
(22 ± 8%) (p < 0.01), SPr (18 ± 6%) (p < 0.01), compared
to control (36 ± 12%). No differences were observed between
control-treated and SAc-treated EC (32 ± 12%) (p = 0.641).
Representative confocal images are shown in Figure 5C. Taken
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FIGURE 4 | Short-chain fatty acid reduces the adhesion of mock- or EHV1-inoculated mononuclear cells to the target endothelium. (A,B) Monocytic cells or (C,D)
T-lymphocytes were co-cultured during 15 (left panel) or 60 min (right panel) with 0, 0.5 or 5 mM SB, SPr, or SAc equine EC. Adherent mononuclear cells were
counted per 100 EC in 5 ad random chosen fields. Viral proteins were stained in green (FITC). (E) Representative confocal images of the binding of EHV1-inoculated
mononuclear cells to the target endothelium, pretreated with SCFA. Three independent experiments were performed and data are represented as means + SD.
Statistical significant differences are shown with asterisks: ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001; ns indicates p > 0.05.
together, it can be concluded that SCFA efficiently downregulate
ICAM-1 and VCAM-1 on the plasma membrane of EC.
SCFA Indirectly Inhibits the Viral Transfer
From Mononuclear Cells to Equine
Endothelial Cells
Next, we checked whether SCFA-mediated downregulation of
ICAM-1 and VCAM-1 eventually results in reduced viral
transfer from EHV1-inoculated monocytic CD172a+ cells and
T-lymphocytes to EC. To this end, the number of viral plaques
upon 36 h of co-cultivation with EC was determined, shown
in Figure 6. The number of viral plaques upon co-cultivation
of monocytic cells and EC was comparable between untreated
and SPr-, and SAc-treated EC (Figure 6A). However, when the
EC were pretreated with 0.5 or 5 mM SB prior to the co-
cultivation with EHV1-inoculated monocytic cells, a reduction
in the number of viral plaques was observed. Only 7 ± 11 viral
plaques were detected in the EC treated with 5 mM SB, compared
to the 100 viral plaques in the control (p < 0.05). Similar results
were observed when EHV1-inoculated T-lymphocytes were co-
cultured with SCFA-treated EC (Figure 6B). The number of viral
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FIGURE 5 | Short-chain fatty acid reduces the expression of adhesion molecules on the endothelial cell surface. The expression of the adhesion molecules
(A) ICAM-1 and (B) VCAM-1 on the EC cell surface after 24 h SCFA treatment, in the presence or absence of LPS, was analyzed. (C) Representative confocal
images of the expression of ICAM-1 and VCAM-1 in the presence or absence of different SCFA. ICAM-1, and VCAM-1 were stained in green (FITC), and nuclei were
counterstained in blue (Hoechst 33342). Three independent experiments were performed and data are represented as means + SD. Statistical significant differences
are shown with asterisks: ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001.
plaques significantly reduced from 100 in the control-treated EC,
to 43 ± 30 plaques when treated with 5 mM SB (p = 0.167).
Representative confocal images are shown in Figure 6C.
In conclusion, upon pretreatment of EC with 0.5 and 5 mM
SB, we demonstrated a reduced number of viral plaques upon co-
cultivation of EHV1-inoculated mononuclear cells with EC. In
contrast, SPr and SAc did not change the number of viral plaques
in the target endothelium.
SCFA Does Not Inhibit Viral Replication
in Equine Endothelial Cells
Since Li et al. (2018) demonstrated the anti-inflammatory effects
of SCFA on endothelial cells, we analyzed whether SCFA directly
affects EHV1 replication in EC. Therefore, the extracellular virus
titer, number of plaques and plaque latitude were determined
in EHV1-inoculated EC upon treatment with 0.5 or 5 mM SB,
SPr, or SAc. No significant alterations in replication kinetics
of EHV1 was observed upon pretreatment, inoculation, and
cultivation in the presence of 0.5 or 5 mM SB, SPr, or SAc
(Figure 7A). Representative confocal images are shown in
Figure 7B. Altogether, we can conclude that SCFA do not have
a significant effect on the viral replication in equine EC in vitro.
DISCUSSION
The mammalian gut represents a complex ecosystem consisting
of an extraordinary number of resident commensal bacteria
which are involved in the development and function of the
immune response (Chow et al., 2010). In addition, bacterial
fermentation metabolites of carbohydrates, such as SCFA, are
known for their protective effects on epithelial cells in the
gut. Once absorbed in the systemic circulation, they positively
affect the general host physiology, including cardiovascular
function, inflammation, and atherosclerosis (Esposito and
Giugliano, 2006; Anderson et al., 2009; Morrison and Preston,
2016). Interestingly, Trompette et al. (2014) demonstrated
that dietary fibers shape the composition of the intestinal,
and to a lesser extent the airway microbiota in mice. This
resulted in major differences in allergic airway responses
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FIGURE 6 | Viral transfer from mononuclear cells to SCFA-pretreated endothelial cells (EC). The number of viral plaques in SCFA-treated EC were analyzed after 36 h
of co-cultivation with EHV1-inoculated (A) monocytic CD172a+ cells, or (B) T-lymphocytes. Number of plaques were counted per 0.25 cm2. Three independent
experiments were performed and data are represented as means + SD. Statistical significant differences are shown with asterisks: ∗ p < 0.05. (C) Representative
confocal images of EHV1 viral plaques in EC. Viral proteins were shown in green (FITC), nuclei were counterstained in blue (Hoechst).
in mice. These results are in line with epidemiological
studies, showing that dietary fibers reduce the incidence
of asthma in humans, associated with a sophisticated
cross-talk between the gastrointestinal and respiratory tract
(Marsland et al., 2015).
Horses are extremely susceptible to disturbance of their
gut microbiota, often resulting in gastro-intestinal disorders.
Because of the increased demands placed on horses for athletic
performances, the fiber-based diet is often supplemented with
varying quantities of high energetic grains and oils (Dougal
et al., 2014). An overload of cereal starch might result in
the rapid microbial fermentation in the hindgut, resulting in
increased lactic acid. This can result in a decreased luminal pH,
which suppresses the growth of obligate fibrolytic acid-intolerant
bacteria, leading to a reduced production of SCFA.
Based on the proven importance of SCFA on the overall
physiology of mammals and the delicate balance of the
microbiome of horses, we hypothesized that systemic fluctuations
of SCFA levels might influence the pathogenesis of viral
infections, which might contribute to individual differences in
clinical outcome. Since EHV1 is a major equine pathogen, which
horses almost invariably encounter at some point in life, we
examined the putative protective effects of SCFA upon primary
EHV1 replication in the URT, viremia, viral transfer to and
replication in the target endothelium.
First we focused on the primary site of EHV1 replication,
the URT. We demonstrated that the two main SCFA receptors,
FFA2 and FFA3, are overall expressed in the respiratory tract,
at the cell surface of immune cells, and endothelium lining the
blood vessels of the horse. These results are in line with the
study of Imoto et al. (2018), demonstrating the prevalence of both
receptors in human sino-nasal tissues. The interaction of SCFA
and FFA2/FFA3 modulates and controls inflammatory responses,
including airway diseases in humans (Trompette et al., 2014).
Despite the described protective effects of SCFA in respiratory
disease, we were not able to detect major differences in primary
EHV1 replication in the URT, after SCFA pretreatment. Virus
titer, plaque latitudes or number of plaques were not altered
in the presence of SCFA. Only SB and SPr reduced the EHV1
plaque latitudes. This could be due to the expression of FFA2
and FFA3, and the efficiency for SCFA binding. Indeed, at
epithelial cell surfaces, SPr and SB bind more efficiently to
FFA2 and/or FFA3, while this binding is less effective for SAc
(Li et al., 2018). In addition, we found an enhanced plaque
sequestration in the presence of SB. One speculative explanation
may be the enhanced mitosis of basal cells in the respiratory
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FIGURE 7 | Analysis of SCFA pretreatment on EHV1 infection of equine EC. (A) Extracellular virus titer (left), viral plaque latitudes (middle), and number of plaques
(right) were analyzed at 24 hpi. (B) Representative confocal images of EHV1 plaques in EC are stained in green (FITC). Nuclei were counterstained in blue (Hoechst).
Five ad random chosen viral plaques were analyzed. Three independent experiments were performed and data are represented as means + SD. Statistical analysis
was performed: ns indicates p > 0.05.
epithelium in the presence of SB (Reichert et al., 2012). However,
immunofluorescence staining of the G2/M-phase specific protein
cyclin B1 could not confirm this hypothesis (data not shown).
In addition, butyrate is the most potent HDAC inhibitor of all
three tested SCFA (Schilderink et al., 2013), facilitating efficient
binding of transcription factors to cellular chromatin, suggesting
an enhanced cell cycle progression. Another putative explanation
could be found in a modulated type I IFN response, leading to the
plaque sequestration. Nusinzon and Horvath (2003) described
a butyrate-mediated enhancement of the phosphorylation of
STAT-1 in the IFN signaling pathway. However, our data are not
in line with such hypothesis, since no increase or decrease in IFN
bioactivity could be observed in the presence of SB, SPr, or SAc.
More research is required to explain the mechanism of plaque
sequestration in the presence of SB.
During EHV1 infection, extravasated monocytic CD172a+
cells and T-lymphocytes are attracted to the infected respiratory
mucosa within 24–36 hpi. Infecting the cellular arm of the
immune response may represent an effective immune evasion
strategy of EHV1 to evade the immune response, to promote
viral dissemination in the host, evade host clearance and establish
latency (van der Meulen et al., 2000; Gryspeerdt et al., 2010;
Vandekerckhove et al., 2010; Laval et al., 2015a, 2017). Here,
we demonstrated that both SCFA receptors were expressed on
the cell surface of leukocytes in the draining lymph nodes,
suggesting that SCFA may affect leukocytes. It has been reported
that SCFA could enter immune cells in a FFA2/FFA3 dependent
or independent manner, via passive diffusion (Smith et al.,
2013). Once entered in leukocytes, SCFA modulates the systemic
inflammation and infection by mediating HDAC activity (Ang
and Ding, 2016). Interestingly, Laval et al. (2015a) demonstrated
that the replication of abortigenic EHV1 variants in monocytic
CD172a+ cells is silenced and strictly regulated by HDAC.
Treatment of the monocytic CD172a+ cells with butyrate
resulted in activation of viral replication, with transcription and
translation of the late viral proteins. In addition, several studies
indicated that SCFA shape the T-cell response, by activating the
mTOR signaling pathway, and by regulating the differentiation of
CD4+ T-cells into Th1 and Th17 cells (Park et al., 2015). Since
SCFA changes the leukocyte phenotype, we focused on the two
main target cells of EHV1 viremia, monocytic CD172a+ cells and
T-lymphocytes. Pretreatment of these immune cells with different
concentrations of SB, SPr, or SAc did not notably increase the
number of EHV1 positive cells. This indicates that SCFA does not
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change the susceptibility of mononuclear cells to EHV1 infection.
However, we demonstrated that extracellular virus titers slightly
increased when monocytic cells were treated with SB, but not
with SPr or SAc. This is not surprising, since principally SB, and
to a lesser extent SPr, are effective HDAC inhibitors (Schilderink
et al., 2013). Treatment of T-lymphocytes with SCFA did not alter
the extracellular virus titer, suggesting that HDAC may not be
involved in EHV1 replication or egress in T-cells.
Following the cell-associated viremia, EHV1-infected immune
cells reach the endothelium lining the blood vessels of the
pregnant uterus or CNS. During this stage of infection adhesion
molecules expressed on both immune cells and EC play a pivotal
role in EHV1 transfer to the endothelium (Laval et al., 2015b).
The firm adhesion of leukocytes to vascular endothelium is
mediated through ICAM-1 and VCAM-1. Here, we showed
that pretreatment of EC with SB, SPr, or SAc inhibited the
expression of VCAM-1, and to a lesser extent ICAM-1 on the
EC surface. ICAM-1 serves as an endothelial counter-receptor
for several leukocyte surface molecules, such as αLβ2 integrin
(or LFA1), and VCAM-1 is the endothelial counter-receptor for
α4β1 integrin (or VLA-4) (Springer, 1994). Interestingly, LFA1
and VLA4 play a fundamental role in the contact between
an EHV1-infected monocytic CD172a+ cells and the adjacent
EC (Laval et al., 2015b). This interaction facilitates direct
viral transfer from the infected monocytic cell, to the engaged
endothelium. Thus, SCFA-mediated downregulation of the
endothelial cell adhesion molecules may lead to reduced adhesion
of mononuclear cells to EC, and subsequently reduced viral
transfer and infection of EC. Our results are in line with Menzel
et al. (2004) and Zapolska-Downar et al. (2004), indicating that
butyrate downregulates the NFκB signaling pathway, resulting
in the downregulation of ICAM-1 and VCAM-1 in human
umbilical endothelial cells (HUVEC). However, we are the
first to demonstrate that SCFA may have a protective effect
at the level of the target endothelium during systemic EHV1
infection. We believe that these results can be extended to other
mammalian (herpes)viruses. Several common human viruses,
including herpes simplex virus 1, human cytomegalovirus,
pseudorabies virus and measles virus, transfer infection from
infected mononuclear cells, to target endothelium (Friedman
et al., 1981; Gosselin et al., 1992; Van de Walle et al., 2003;
Goodrum and Bughio, 2015). More research is required to
unravel the beneficial effects of SCFA in the pathogenesis of other
life-threatening viruses.
In conclusion, our results indicate that physiological SCFA
levels temper the EHV1 pathogenesis ex vivo and in vitro. SB and
SPr mainly inhibits the lateral spread of EHV1 in the URT, while
SAc reduces the number of EHV1-infected monocytic CD172a+
cells. SB decreases the adhesion of infected mononuclear cells to
EC by reducing the membrane expression of crucial endothelial
adhesion molecules. These results contribute to the hypothesis
that clinical EHV1 manifestations can be diminished by correct
management and nutrition.
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